Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial

This publication has 34 references indexed in Scilit:

• Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine
  AIDS, 2007
• Impact of Nevirapine (NVP) Plasma Concentration on Selection of Resistant Virus in Mothers Who Received Single-Dose NVP To Prevent Perinatal Human Immunodeficiency Virus Type 1 Transmission and Persistence of Resistant Virus in Their Infected Children
  Antimicrobial Agents and Chemotherapy, 2007
• Rapid Scale-up of Antiretroviral Therapy at Primary Care Sites in Zambia
  JAMA, 2006
• Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission
  AIDS, 2006
• Evidence that Low-Level Viremias during Effective Highly Active Antiretroviral Therapy Result from Two Processes: Expression of Archival Virus and Replication of Virus
  Journal of Virology, 2005
• Prevention of mother to child transmission of HIV: evaluation of a pilot programme in a district hospital in rural Zimbabwe
  BMJ, 2004
• Comparison of Nevirapine (NVP) Resistance in Ugandan Women 7 Days vs. 6–8 Weeks after Single-Dose NVP Prophylaxis: HIVNET 012
  AIDS Research and Human Retroviruses, 2004
• Prospective Randomized Trial of Emtricitabine versus Lamivudine Short‐Term Monotherapy in Human Immunodeficiency Virus–Infected Patients
  The Journal of Infectious Diseases, 2003
• Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia
  AIDS, 2003
• Nevirapine quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry. Application to bioequivalence study
  Journal of Mass Spectrometry, 2002